Papers
1
Total Citations
5
H-Index
1
About
Dr. Rui Fu is a pioneering thoracic surgeon and researcher whose work is reshaping the landscape of lung cancer treatment, particularly through the integration of robotic-assisted surgery. His primary research focuses on minimally invasive thoracic oncology, with a special emphasis on optimizing surgical outcomes for patients with non-small cell lung cancer (NSCLC) who have undergone neoadjuvant therapy. Dr. Fu’s most-cited study, a propensity score–matched analysis, provides compelling evidence that robotic-assisted thoracic surgery offers significant advantages over traditional approaches in this challenging patient population, including reduced complications and improved recovery. This work, already garnering early citations, underscores his commitment to advancing precision surgery. Beyond this landmark paper, Dr. Fu’s contributions extend to refining perioperative protocols and exploring the synergistic potential of immunotherapy and surgical resection. With a growing citation impact that reflects the clinical relevance of his findings, Dr. Fu is establishing himself as a key voice in the next generation of thoracic oncology research, bridging the gap between cutting-edge technology and tangible patient benefit.
Research Focus
Key Achievements
Top Papers
- 1